n | Anti-HBs and/or anti-HBc pos (%) | Anti-HBc pos (%) | Anti-HBs pos (%) | Only Anti-HBc pos (%) | Only Anti-HBs pos (%) | No HBV marker detected (%) | |
---|---|---|---|---|---|---|---|
Overall | 53 | 24 (45.3) | 19 (35.8) | 11 (20.7) | 13 (24.5) | 5 (9.4) | 29 (54.7) |
Sex | |||||||
Male | 41 | 19 (46.3) | 16 (39.0) | 8 (19.5) | 11 (26.8) | 3 (7.3) | 22 (53.6) |
Female | 12 | 5 (41.7) | 3 (25) | 3 (25) | 2 (16.7) | 2 (16.7) | 7 (58.3) |
Risk factors a | |||||||
Heterosexual | 46 | 20 (43.5) | 16 (34.8) | 8 (17.4) | 12 (26.1) | 4 (8.7) | 26 (56.6) |
Transfusion | 3 | 2 (66.7) | 1 (33.3) | 2 (66.7) | 0 | 1 (33.3) | 1 (33.3) |
IVDU | 2 | 2 (100) | 2 (100) | 1 (50) | 1 (50) | 0 | 0 |
CD4 cell counts | |||||||
≤ 200 | 35 | 15 (42.8) | 12 (34.3) | 4 (11.4) | 11 (31.4) | 3 (8.5) | 20 (57.1) |
201-499 | 12 | 7 (58.3) | 5 (41.7) | 6 (50) | 1 (8.3) | 2 (16.7) | 5 (41.6) |
≥ 500 | 6 | 2 (33.3) | 2 (33.3) | 1 (16.7) | 1 (16.7) | 0 | 4 (66.7) |
ALT levels | |||||||
Normal | 30 | 14 (46.6) | 11 (36.6) | 8 (26.6) | 6 (20) | 4 (13.3) | 16 (53.3) |
Raised b | 23 | 10 (43.4) | 8 (34.7) | 3 (13.0) | 7 (30.4) | 1 (4.3) | 13 (56.5) |
Other co-infections | |||||||
HCV pos c | 5 | 4 (80) | 3 (60) | 2 (40) | 2 (40) | 1 (20) | 1 (20) |
TB pos d | 17 | 6 (35.3) | 5 (29.4) | 3 (17.6) | 3 (17.6) | 1 (5.9) | 11 (64.7) |